McKesson Corp (MCK)

Wholesale-Drugs, Proprietaries & Druggists' Sundries

Latest Price

$994.58

TTM P/E

26.68

Normalized P/E

39.66

TTM Div Yield

0.33%

Fwd Div Yield

0.33%

Book Value

P/B Ratio

Valuation metrics

Norm. op. income: $3.9B (median of 7yr)

Tax rate: 19%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$243.30

76% downside

Base FCF: $4.8B (median of recent 5yr)

Growth: 3%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$542.56

45% downside

EPS: $38.38

Target P/E: 40×

Formula: EPS × P/E

P/E Fair Value

$1,535.20

+54% upside

90.2% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	10.80M	$8.16B	9.31%	-635.8K	2026-06-30
Vanguard Capital Management LLC	7.85M	$5.93B	6.77%	-107.6K	2026-06-30
State Street Corp	5.73M	$4.33B	4.94%	-4.6K	2026-06-30
Morgan Stanley	5.31M	$4.01B	4.57%	+3.01M	2026-06-30
Franklin Resources Inc	2.91M	$2.19B	2.50%	-158.0K	2026-06-30
Vanguard Portfolio Management LLC	2.87M	$2.17B	2.48%	-9.9K	2026-06-30
Geode Capital Management, LLC	2.82M	$2.12B	2.43%	-81.7K	2026-06-30
Massachusetts Financial Services Co	2.45M	$1.86B	2.11%	-453.8K	2026-06-30
FMR LLC	2.13M	$1.61B	1.84%	-1.47M	2026-06-30
JPMorgan Chase & Co	1.75M	$1.31B	1.51%	-840.4K	2026-06-30